A Phase I Study of LY2584702 in Patient With Advanced or Metastatic Cancer.

Trial Profile

A Phase I Study of LY2584702 in Patient With Advanced or Metastatic Cancer.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 15 Jan 2014

At a glance

  • Drugs LY 2584702 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 10 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 16 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top